SAB Biotherapeutics Inc. (SABS): Total Asset Value of Company
The market valuation dynamics for SAB Biotherapeutics (SABS) based on total assets stand at 134.17. SAB Biotherapeutics develops high-demand medications for diabetics by utilizing modified livestock to produce antibodies. However, high expenditures on research centers are leading to a gradual depletion of cash reserves. Process efficiency is maintained through the implementation of autonomous bioreactors, which minimize human error during the cultivation of biomaterials.
Comprehensive metric breakdowns and analytics for SAB Biotherapeutics, Inc (SABS)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio SAB Biotherapeutics|SABS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio SAB Biotherapeutics Inc|SABS - Company Aggregate Debts|Debts to Book Capitalization SAB Biotherapeutics Inc|SABS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings SAB Biotherapeutics
Fundamental valuation:SABS, sabbiotherapeutics.com
Investors utilize the dynamics of total resources as an indicator of business scalability and its ability to generate profit per unit of investment. This metric is calculated inversely via return on assets (ROA), and the analysis of asset and resource forecasts confirms the financial stability of SAB Biotherapeutics (SABS), which is supported by transparent government contracts with the Pentagon and the development of a unique immunotherapy platform.
Competitors of SAB Biotherapeutics (SABS)
ARGX (argenx.com) - Company Total Asset Base|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Pieris Pharma - Company Assets|Aggregate Company Assets SVRA (Savara Corp)|RIGL - Company Total Asset Base|ANAB: Company Total Assets|astriatx.com (ATXS) - Company Total Assets|Company Total Assets enGene|Aggregate Company Assets RAPT Therapeutics Inc. (RAPT)|Aerovate Therapeutics Inc (JBIO) - Cumulative Company Assets|Aggregate Asset Value Aclaris Therapeutics, Inc (ACRS)|Company Total Assets Kyverna Therapeutics KYTX|Aggregate Company Assets tizianalifesciences.com TLSA|Company Total Assets CABA (Cabaletta Bio)|VTYX: Company Total Asset Base|Aggregate Company Assets THTX|Company Assets Avalo Therapeutics Inc|Eledon Pharmaceuticals (ELDN) - Cumulative Company Assets|Aggregate Business Assets agenusbio.com|Climb Bio (CLYM) - Company Total Assets|Aggregate Asset Value Zura Bio Ltd (ZURA)|ATYR: Company Total Assets|Adagene Inc - Company Assets|Aggregate Company Assets Ikena Oncology, Inc. (IMA)|STTK - Aggregate Asset Value|EQ: Company Total Assets|CNTB (Connect Biopharma Holdings Limited) - Company Total Assets|Aggregate Company Assets Immunic Therapeutics IMUX|Total Asset Value of Company Atara Biotherapeutics Inc|InflaRx N.V. - Company Total Assets|Company Assets x4pharma.com XFOR|Cumulative Company Assets ACET (Adicet Bio, Inc.)|CELU - Company Total Assets|Cumulative Company Assets INmune Bio Corp INMB|BRNS - Aggregate Business Assets|Kezar Life Sciences - Company Total Assets|akaritx.com (AKTX) - Company Total Asset Base|Company Total Assets ENLV|Cumulative Company Assets QTTB|GOVX (GeoVax Labs Inc) - Aggregate Company Assets|Company Total Asset Base EDSA (Edesa Biotech Corp)|Aggregate Company Assets IBIO|Company Total Asset Base Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals Ltd. - Company Total Assets|BOLT - Company Total Assets|hcwbiologics.com (HCWB) - Company Total Assets|APVO (Aptevo Therapeutics Inc.) - Aggregate Company Assets|AIM: Aggregate Company Assets|Company Total Asset Base ADTX|GRI - Aggregate Company Assets|Total Asset Value of Company XORTX Therapeutics Inc (XRTX)|Company Total Assets ReShape Lifesciences|Aggregate Asset Value Revelation Biosciences Corp REVB|Indaptus Therapeutics - Company Total Assets|SCNI: Company Total Assets|Aggregate Company Assets calcimedica.com CALI|AFMD (Affimed N.V.) - Aggregate Asset Value|Aggregate Company Assets ALLK|Cumulative Company Assets HOOKIPA|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com ITOS|Cumulative Company Assets Ocean Biomedical|Aggregate Asset Value TC BioPharm (Holdings) Plc TCBP|Company Total Assets THRD (Third Harmonic Bio, Inc)